Get started
Author

Foojan Zeine

Observed names: Zeine Foojan, Zeine, Foojan
ORCID: 0009-0006-7709-5580
Observed ORCID: 0009-0006-7709-5580
OpenAlex ID: A5020041640
Neurogenetics and Epigenetics of Loneliness
2023 · Abdalla Bowirrat, Igor Elman, et al. · Psychology Research and Behavior Management · 23
PDF
Awareness Integration: A New Therapeutic Model
2014 · Foojan Zeine · International Journal of Emergency Mental Health and Human Resilience · 15
Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS).
2023 · Kenneth Blum, Abdala Bowirrat, et al. · PubMed · 12
PDF
Awareness integration theory A Psychological and genetic path to self-directed Neuroplasticity
2024 · Foojan Zeine, Nicole Jafari, et al. · Health Sciences Review · 7
Awareness Integration: An AlternativeTherapeutic Methodology to Reducing Depression, Anxiety, While Improving Low Self- Esteem and Self-Efficacy in Separated or Divorced Individuals
2017 · Foojan Zeine, Nicole Jafari, et al. · Mental Health in Family Medicine · 5
Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects
2025 · Kai-Uwe Lewandrowski, Kenneth Blum, et al. · Journal of Personalized Medicine · 4
Invited Expert Opinion- Bio-informatic and Limitation Di-rectives to Help Adopt Ge-netic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Re-quired Analytic Evidence to Induce Dopamine Homeo-statsis
2023 · Kenneth Blum, Mark Gold, et al. · Medical Research Archives · 4
PDF
Exploring dopamine as the master regulator of brain circuitry and mental health genome
2025 · Kenneth Blum, Eric R. Braverman, et al. · Gene & Protein in Disease · 3
Hypothesizing glucagon-like peptide 1 (GLP-1), agonists promote hypodopaminergia, resulting in heightened addictive reward-seeking and altered mood: Breaking the bubble and adding salt to a wound
2025 · Kenneth Blum, Catherine A. Dennen, et al. · Medical Hypotheses · 3
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy
2024 · Foojan Zeine, Nicole Jafari, et al. · Journal of Addiction Psychiatry · 3
PDF
Awareness Integration Therapy for Generalized Anxiety Disorder
2022 · Madani Hila S, Zeine Foojan · International Journal of Psychiatry Research · 3
PDF
Self Identity through the Lens of Awareness Integration Theory: Encouraging Novel Empirical Research to Uncover Molecular Neurobiological Correlates
2025 · Foojan Zeine · Medical Research Archives · 2
PDF
Enhancing Mental Health Support: Integrating Artificial Intelligence Powered Mobile Apps and Chatbots for Psychoeducation and Skill-Building
2025 · Foojan Zeine, Sam Changizi · Medical Research Archives · 2
PDF
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development
2024 · Kenneth Blum, Eric R. Braverman, et al. · INNOSC Theranostics and Pharmacological Sciences · 2
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies
2024 · Kenneth Blum, Igor Elman, et al. · Open Journal of Immunology · 2
PDF
Are We Getting High Cause the Thrill is Gone?
2023 · Kenneth Blum, Thomas Mclaughlin, et al. · Journal of Addiction Psychiatry · 2
PDF
Multimodal Neurofunctional Assessment of a Single-Session Awareness Integration Therapy Outcomes: A Case Study
2026 · Foojan Zeine, Bashar Qatanany, et al. · Applied Psychophysiology and Biofeedback · 1
Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery
2026 · Kenneth Blum, Mark Gold, et al. · Psychology Research and Behavior Management · 1
Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals
2025 · Kenneth Blum, Alireza Sharafshah, et al. · Research Square · 1
PDF
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia
2025 · Kai-Uwe Lewandrowski, Kenneth Blum, et al. · Frontiers in Public Health · 1
PDF
Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia
2025 · Kai-Uwe Lewandrowski, Kenneth Blum, et al. · Frontiers in Public Health · 1
PDF
GWAS meta-meta-analysis and related analyses revealed a shared genetic background between ADHD and narcolepsy
2025 · Edward J. Modestino, Alireza Sharafshah, et al. · Academia molecular biology and genomics. · 1
Pre-addiction phenotype is associated with dopaminergic dysfunction: Evidence from 88.8 million genome-wide association study-based samples
2025 · Kenneth Blum, Alireza Sharafshah, et al. · Gene & Protein in Disease · 1
Awakened Leadership
2025 · Behnam Bakhshandeh, Foojan Zeine · Productivity Press eBooks · 1
Addictive Behavior and Evolutionary Adaptation: Mitigated through Genetic Addiction Risk Severity Early Identification and Awareness Integration Theory
2024 · Foojan Zeine, Nicole Jafari, et al. · Medical Research Archives · 1
Works count: 53
Citation count: 103
H-index: 5
I10-index: 3
Year
Topic
Type